|
AAPL
|
Technology |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$4.5T
|
$25.68
|
-2.1%
|
-1.9%
|
-4.2%
|
+0.5%
|
+1.6%
|
+1.5%
|
|
MSFT
|
Technology |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$3.1T
|
$55.05
|
-1.3%
|
-1.8%
|
-3.5%
|
+0.3%
|
-0.1%
|
+0.9%
|
|
ORCL
|
Technology |
Evercore ISIC |
Upgrade
|
Hold
→
Buy
|
—
|
$520.1B
|
$35.64
|
-0.4%
|
+0.5%
|
-2.2%
|
-1.1%
|
+0.8%
|
+1.2%
|
|
PG
|
Consumer Defensive |
Atlantic Equities |
Maintains
|
Neutral
→
Neutral
|
—
|
$346.8B
|
$78.62
|
-1.2%
|
-1.0%
|
-0.9%
|
-1.6%
|
+0.9%
|
-0.2%
|
|
BABA
|
Consumer Cyclical |
Baird |
Maintains
|
Outperform
→
Outperform
|
—
|
$324.7B
|
$78.63
|
-1.9%
|
-1.7%
|
-6.0%
|
-2.6%
|
-1.2%
|
+3.9%
|
|
SAP
|
Technology |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$210.1B
|
$76.97
|
-0.2%
|
+0.9%
|
-0.6%
|
-0.4%
|
+2.2%
|
+2.3%
|
|
ANET
|
Technology |
JP Morgan |
Maintains
|
Neutral
→
Neutral
|
—
|
$179.2B
|
$4.89
|
-0.8%
|
-5.9%
|
-6.5%
|
+0.0%
|
-1.2%
|
-2.1%
|
|
TMO
|
Healthcare |
Avondale Partners |
Maintains
|
Market Outperform
→
Outperform
|
—
|
$168.8B
|
$138.51
|
-1.4%
|
-0.8%
|
-2.3%
|
-0.1%
|
+0.5%
|
+1.5%
|
|
TMO
|
Healthcare |
Deutsche Bank |
Maintains
|
Buy
→
Buy
|
—
|
$168.8B
|
$138.51
|
-1.4%
|
-0.8%
|
-2.3%
|
-0.1%
|
+0.5%
|
+1.5%
|
|
SHOP
|
Technology |
Baird |
Maintains
|
Outperform
→
Outperform
|
—
|
$131.8B
|
$2.53
|
-1.4%
|
-0.0%
|
-2.5%
|
+1.1%
|
-4.3%
|
-0.5%
|
|
LMT
|
Industrials |
RBC CapitalB |
Upgrade
|
Sector Perform
→
Outperform
|
—
|
$122.1B
|
$218.26
|
-0.2%
|
-0.3%
|
-2.0%
|
-0.2%
|
+1.1%
|
+1.2%
|
|
CME
|
Financial Services |
Credit Suisse |
Maintains
|
Neutral
→
Neutral
|
—
|
$108.9B
|
$89.37
|
-1.1%
|
-0.5%
|
-1.6%
|
-1.5%
|
+0.8%
|
+0.3%
|
|
ADBE
|
Technology |
Credit Suisse |
Maintains
|
Neutral
→
Neutral
|
—
|
$108.2B
|
$92.34
|
-1.3%
|
-1.4%
|
-2.1%
|
-1.4%
|
+1.7%
|
+0.5%
|
|
MCK
|
Healthcare |
Raymond James |
Downgrade
|
Strong Buy
→
Outperform
|
—
|
$97.6B
|
$195.50
|
-1.9%
|
-1.2%
|
-2.7%
|
-2.9%
|
-10.3%
|
+0.3%
|
|
FTNT
|
Technology |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$95.5B
|
$5.97
|
-1.5%
|
-1.2%
|
-1.2%
|
-1.9%
|
-0.9%
|
+1.4%
|
|
HCA
|
Healthcare |
Longbow Research |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$93.4B
|
$66.44
|
-1.4%
|
-0.7%
|
-2.6%
|
-0.0%
|
+5.5%
|
-1.7%
|
|
HCA
|
Healthcare |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$93.4B
|
$66.44
|
-1.4%
|
-0.7%
|
-2.6%
|
-0.0%
|
+5.5%
|
-1.7%
|
|
EPD
|
Energy |
Scotia Howard Weil |
Maintains
|
Sector Outperform
→
Outperform
|
—
|
$87.1B
|
$26.21
|
-1.6%
|
-4.3%
|
-3.6%
|
+0.3%
|
-4.7%
|
+1.1%
|
|
PNC
|
Financial Services |
Nomura |
Downgrade
|
Buy
→
Neutral
|
—
|
$84.0B
|
$93.29
|
-2.1%
|
-1.8%
|
-2.5%
|
-1.5%
|
+0.4%
|
+0.8%
|
|
CI
|
Healthcare |
Barclays |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$77.5B
|
$144.14
|
-0.5%
|
-0.8%
|
-1.2%
|
-1.9%
|
-2.9%
|
+3.2%
|